List of Excipients in API eslicarbazepine acetate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing eslicarbazepine acetate
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Sumitomo Pharma America Inc | APTIOM | eslicarbazepine acetate | 63402-202 | CROSCARMELLOSE SODIUM | |
Sumitomo Pharma America Inc | APTIOM | eslicarbazepine acetate | 63402-202 | MAGNESIUM STEARATE | |
Sumitomo Pharma America Inc | APTIOM | eslicarbazepine acetate | 63402-202 | POVIDONE K30 | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing eslicarbazepine acetate
Detailed excipient profiles for eslicarbazepine acetate
Excipient focus: CROSCARMELLOSE SODIUM
eslicarbazepine acetate drug variants containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | eslicarbazepine acetate | 31722-428 |
Sumitomo Pharma America Inc | eslicarbazepine acetate | 63402-202 |
>Company | >Ingredient | >NDC |
eslicarbazepine acetate drug variants not containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL MONOSTEARATE
eslicarbazepine acetate drug variants containing GLYCERYL MONOSTEARATE
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | eslicarbazepine acetate | 31722-428 |
>Company | >Ingredient | >NDC |
eslicarbazepine acetate drug variants not containing GLYCERYL MONOSTEARATE
Company | Ingredient | NDC |
---|---|---|
Sumitomo Pharma America Inc | eslicarbazepine acetate | 63402-202 |
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
eslicarbazepine acetate drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Sumitomo Pharma America Inc | eslicarbazepine acetate | 63402-202 |
>Company | >Ingredient | >NDC |
eslicarbazepine acetate drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | eslicarbazepine acetate | 31722-428 |
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
eslicarbazepine acetate drug variants containing POVIDONE K30
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | eslicarbazepine acetate | 31722-428 |
Sumitomo Pharma America Inc | eslicarbazepine acetate | 63402-202 |
>Company | >Ingredient | >NDC |
eslicarbazepine acetate drug variants not containing POVIDONE K30
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K90
eslicarbazepine acetate drug variants containing POVIDONE K90
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | eslicarbazepine acetate | 31722-428 |
>Company | >Ingredient | >NDC |
eslicarbazepine acetate drug variants not containing POVIDONE K90
Company | Ingredient | NDC |
---|---|---|
Sumitomo Pharma America Inc | eslicarbazepine acetate | 63402-202 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM STEARYL FUMARATE
eslicarbazepine acetate drug variants containing SODIUM STEARYL FUMARATE
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | eslicarbazepine acetate | 31722-428 |
>Company | >Ingredient | >NDC |
eslicarbazepine acetate drug variants not containing SODIUM STEARYL FUMARATE
Company | Ingredient | NDC |
---|---|---|
Sumitomo Pharma America Inc | eslicarbazepine acetate | 63402-202 |
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.